NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy

References

• Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12:127–136.
   PubMed Web of Science ®Google Scholar
• Gupta T, Kannan S, Ghosh-Laskar S, et al. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma. PLoS One. 2018;13:e0200137.
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Lambin P, De Ruysscher D, et al. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013;107:267–273.
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Doornaert P, Rietveld DH, et al. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol. 2009;90:189–195.
   PubMed Web of Science ®Google Scholar
• Beetz I, Schilstra C, van der Schaaf A, et al. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. Radiother Oncol. 2012;105:101–106.
   PubMed Web of Science ®Google Scholar
• Christianen ME, Schilstra C, Beetz I, et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2012;105:107–114.
   PubMed Web of Science ®Google Scholar
• Brondum L, Alsner J, Sorensen BS, et al. Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial. Acta Oncol. 2018;57:1159–1164.
   PubMed Web of Science ®Google Scholar
• Eriksen JG, Maare C, Johansen J, et al. OC-0271: 5-Y update of the randomized phase III trial DAHANCA19: primary (Chemo) RT ± zalutumumab in HNSCC. Radiother Oncol. 2018;127:S137–S138.
   Web of Science ®Google Scholar
• Zukauskaite R, Hansen CR, Brink C, et al. Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods. Acta Oncol. 2017;56:1554–1561.
   PubMed Web of Science ®Google Scholar
• Zukauskaite R, Hansen CR, Grau C, et al. Local recurrences after curative IMRT for HNSCC: effect of different GTV to high-dose CTV margins. Radiother Oncol. 2018;126:48–55.
   PubMed Web of Science ®Google Scholar
• Westberg J, Krogh S, Brink C, et al. A DICOM based radiotherapy plan database for research collaboration and reporting. J Phys Conf Ser. 2014;489:012100.
   Google Scholar
• Brink C, Lorenzen EL, Krogh SL, et al. DBCG hypo trial validation of radiotherapy parameters from a national data bank versus manual reporting. Acta Oncol. 2018;57:107–112.
   PubMed Web of Science ®Google Scholar
• Samsøe E, Andersen E, Hansen CR, et al. PO-0944: radiotherapy QA of the DAHANCA 19 protocol. Radiother Oncol. 2015;115:S494–S495.
   Google Scholar
• Brouwer CL, Steenbakkers RJ, Bourhis J, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol. 2015;117:83–90.
   PubMed Web of Science ®Google Scholar
• Hansen CR, Johansen J, Kristensen CA, et al. Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial. Acta Oncol. 2015;54:1669–1673.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Jovanovic A, Godballe C, et al. The Danish Head and Neck Cancer database. Clin Epidemiol. 2016;8:491–496.
   PubMed Web of Science ®Google Scholar
• Vergouwe Y, Nieboer D, Oostenbrink R, et al. A closed testing procedure to select an appropriate method for updating prediction models. Statist Med. 2017;36:4529–4539.
   PubMed Web of Science ®Google Scholar
• Mortensen HR, Overgaard J, Jensen K, et al. Factors associated with acute and late dysphagia in the DAHANCA 6 and 7 randomized trial with accelerated radiotherapy for head and neck cancer. Acta Oncol. 2013;52:1535–1542.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Bentzen SM, Jackson A, et al. Improving normal tissue complication probability models: the need to adopt a “data-pooling” culture. Int J Radiat Oncol Biol Phys. 2010;76:S151–S154.
   PubMed Web of Science ®Google Scholar
• Lambin P, Roelofs E, Reymen B, et al. 'Rapid Learning health care in oncology' – an approach towards decision support systems enabling customised radiotherapy. Radiother Oncol. 2013;109:159–164.
   PubMed Web of Science ®Google Scholar
• Lambin P, Zindler J, Vanneste B, et al. Modern clinical research: how rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine. Acta Oncol. 2015;54:1289–1300.
   PubMed Web of Science ®Google Scholar
• Roelofs E, Persoon L, Nijsten S, et al. Benefits of a clinical data warehouse with data mining tools to collect data for a radiotherapy trial. Radiother Oncol. 2013;108:174–179.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Roelofs E, Ramaekers BL, et al. Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer: comparison of dose, toxicity and cost-effectiveness. Radiother Oncol. 2016;118:281–285.
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76:S10–S19.
   PubMed Web of Science ®Google Scholar
• Jensen K, Bonde Jensen A, Grau C. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol. 2006;78:298–305.
   PubMed Web of Science ®Google Scholar